Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective NR2B antagonists

Selective NR2B antagonists

US Patent 8841301 · Granted Sep 23, 2014

Estimated economic value: $409,229,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treatment of diseases involving acidic or hypoxic diseased tissues2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RI2024
Oligonucleotides for modulating Tau expression2024
Aminotriazolopyridines as kinase inhibitors2024
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency vir2024
Indazole carboxamides as kinase inhibitors2024
Phosphorus (V)-based reagents, processes for the preparation thereof, and their 2024
Biaryl kinase inhibitors2024
Substituted bicyclic compounds useful as T cell activators2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds2024